Middle East and Africa Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Analyte Type, Application, and End User

Middle East and Africa Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Analyte Type, Application, and End User

  • July 2021 •
  • 135 pages •
  • Report ID: 6134344 •
  • Format: PDF
The Middle East and Africa molecular quality controls market is expected to reach US$ 12.52 million by 2028 from US$ 6.87 million in 2021; it is estimated to grow at a CAGR of 9.0% from 2021 to 2028.

Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth.

Genome sequencing has now become one of the common techniques in clinical practices.As per the study ‘Integrating Genomics into Healthcare’, over the next a few years, the healthcare sector is expected to generate genomic data of over 60 million patients.

The growing implementation of genomic sequencing in healthcare systems is supported by substantial government investments, totaling over US$ 4 billion by at least 14 countries.Such continuous funding by the manufacturers and governments in the field of genomics is supporting the growth of the molecular quality controls market.

Also, the cost of genome sequencing, as well as next-generation sequencing, has dropped radically in the past 6–7 years.Moreover, the process requires a lesser number of days for completion.

Lowering costs and accelerating overall process enable service providers to secure larger profit margins, along with helping them expand their clientele. Thus, the lowered cost of genome sequencing is propelling the number of molecular biology procedures carried out for different purpose, thereby driving the use of molecular quality controls. Additionally, molecular diagnostics methodologies are used for detecting disturbance between specific sequences in DNA or RNA. The irregularities such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions lead to various diseases such as infectious diseases, cancer, viral diseases, and sexually transmitted diseases (STDs). Hence, high prevalence of infectious diseases and increasing incidence of cancer lead to high traction toward molecular diagnostics, as it is capable of diagnosing diseases with high specificity, further paving the way for treating patients with precision medicine. Various governments are focused on research and development in the field of precision medicine.

The recent pandemic is causing turbulence to the economies of the Middle East region.The Saudi government policies are favored of domestic pharmaceutical manufacturers including not any import duties on raw materials & intermediate products and interest-free funding support the growth of the pharmaceutical market in this region.

Similarly, increasing incidence of COVID-19 create huge demand for kits and reagent used in detection of COVID-19 virus. As molecular quality controls majorly used in detection of novel coronavirus, so there was positive impact of COVID-19 on the molecular quality controls market.

The Middle East and Africa molecular quality controls market, by product, is segmented into independent controls and instrument specific controls. The independent controls segment held a larger share of the market in 2020 whereas the same is anticipated to register the highest CAGR in the market during the forecast period.

Based on analyte type, the Middle East and Africa molecular quality controls market has been segmented into single analyte controls and multi-analyte controls. The single analyte controls segment held a larger share of the market in 2020, whereas the multi-analyte control segment is estimated to register the highest CAGR in the market during the forecast period.

The Middle East and Africa molecular quality control market, by application, is segmented into, infectious diseases, oncology, genetic testing, and other applications. The infectious diseases segment held the largest share of the market in 2020, whereas the oncology segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on end user, the Middle East and Africa molecular quality control market is segmented into clinical laboratories, hospitals, IVD manufacturers & contract research organizations, academic & research institutes, and other end users. The clinical laboratories segment held the largest share of the market in 2020 and is estimated to register the highest CAGR in the market during the forecast period.

A few of the primary and secondary sources associated with this report on the Middle East and Africa molecular quality control market are the Ethiopian Biotechnology Institute (EBti), Dubai Health Authority (DHA) and Saudi Human Genome Program (SHGP).
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.